- Home
- ACIU vs UTMD Comparison
ACIU vs UTMD Comparison
Compare ACIU & UTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- UTMD
- Stock Information
- Founded
- ACIU 2003
- UTMD 1978
- Country
- ACIU Switzerland
- UTMD United States
- Employees
- ACIU N/A
- UTMD N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- UTMD Medical/Dental Instruments
- Sector
- ACIU Health Care
- UTMD Health Care
- Exchange
- ACIU Nasdaq
- UTMD Nasdaq
- Market Cap
- ACIU 213.3M
- UTMD 177.4M
- IPO Year
- ACIU 2016
- UTMD N/A
- Fundamental
- Price
- ACIU $2.97
- UTMD $54.85
- Analyst Decision
- ACIU Strong Buy
- UTMD
- Analyst Count
- ACIU 2
- UTMD 0
- Target Price
- ACIU $10.00
- UTMD N/A
- AVG Volume (30 Days)
- ACIU 266.4K
- UTMD 11.2K
- Earning Date
- ACIU 11-04-2025
- UTMD 10-23-2025
- Dividend Yield
- ACIU N/A
- UTMD 2.19%
- EPS Growth
- ACIU N/A
- UTMD N/A
- EPS
- ACIU N/A
- UTMD 3.54
- Revenue
- ACIU $5,482,957.00
- UTMD $38,633,000.00
- Revenue This Year
- ACIU N/A
- UTMD N/A
- Revenue Next Year
- ACIU $1,022.98
- UTMD N/A
- P/E Ratio
- ACIU N/A
- UTMD $15.75
- Revenue Growth
- ACIU N/A
- UTMD N/A
- 52 Week Low
- ACIU $1.43
- UTMD $51.26
- 52 Week High
- ACIU $4.00
- UTMD $65.91
- Technical
- Relative Strength Index (RSI)
- ACIU 44.78
- UTMD 40.19
- Support Level
- ACIU $2.70
- UTMD $53.80
- Resistance Level
- ACIU $3.13
- UTMD $55.98
- Average True Range (ATR)
- ACIU 0.21
- UTMD 1.23
- MACD
- ACIU -0.05
- UTMD 0.16
- Stochastic Oscillator
- ACIU 32.50
- UTMD 41.87
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.